SCHEMBL6252924

SCHEMBL6252924

N#Cc1c(N)nc(SCC(N)=O)c(C#N)c1-c1cccs1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.81
MAPT P10636 10/20 0.81
HTT P42858 3/20 0.81
KDM4E B2RXH2 11/20 0.74
MEN1 O00255 9/20 0.74
KMT2A Q03164 9/20 0.74
NPSR1 Q6W5P4 6/20 0.74
RXFP1 Q9HBX9 5/20 0.74
TSHR P16473 3/20 0.74
HSD17B10 Q99714 5/20 0.72
LMNA P02545 3/20 0.72
ADORA1 P30542 4/20 0.71
ADORA2B P29275 4/20 0.71
ADORA3 P0DMS8 3/20 0.71
HPGD P15428 10/20 0.67
GAA P10253 3/20 0.67
RECQL P46063 1/20 0.67
SMN1; SMN2 Q16637 2/20 0.65
MAPK10 P53779 1/20 0.65
STAT6 P42226 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6254233 0.91 ALDH1A1 (0.68) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL7016994 0.83 ADORA1 (1.00) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL13913671 0.82 ADORA1 (0.71) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL2279737 0.80 ADORA1 (0.80) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL6441319 0.80 ADORA1 (0.69) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL5040253 0.80 ALDH1A1 (0.85) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL18313857 0.80 ALDH1A1 (0.64) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL13913723 0.79 ALDH1A1 (0.71) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL6442951 0.79 KDM4E (0.68) ALDH1A1MAPTHTTKDM4EMEN1
SCHEMBL4471026 0.79 ALDH1A1 (0.76) ALDH1A1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005058315-A1 NOVEL HETEROCYCLIC COMPOUNDS AS IKK2 INHIBITORS WITH ANTI-HBV ACTIVITY RIBAPHARM, INC. (US) 2005-06-30 WO disclosed